| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/18/1996 | WO1995034323A3 Proteinaceous adjuvants |
| 01/18/1996 | WO1995034320A3 Methods for inhibiting antigen specific t cell responses |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | CA2194239A1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 01/18/1996 | CA2193489A1 Anti-hiv triple combination |
| 01/18/1996 | CA2193399A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | CA2192565A1 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0691988A1 Inhibitor of stem cell proliferation and uses thereof |
| 01/17/1996 | EP0691986A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS |
| 01/17/1996 | EP0691966A1 Quinolines as type iv phosphodiesterase inhibitors |
| 01/17/1996 | EP0691848A1 Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic |
| 01/17/1996 | EP0691845A1 Use of cis- or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases |
| 01/17/1996 | EP0602028B1 Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | EP0521916B1 Use of il-4 to enhance immune response to infectious antigenic challenges |
| 01/17/1996 | EP0314705B1 A novel family of primate hematopoietic growth factors |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/17/1996 | CN1030702C 芪衍生物 Stilbene derivatives |
| 01/16/1996 | US5484942 Chemical intermediates for compounds that are antagonist for substance p such as analgesics, antiinflammatory agents, cns agents, antispasmodics or immunological effects |
| 01/16/1996 | US5484805 Heterocyclene derivatives |
| 01/16/1996 | US5484711 DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI |
| 01/16/1996 | CA1337937C Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/11/1996 | WO1996000587A1 Aav capsid vehicles for molecular transfer |
| 01/11/1996 | WO1996000583A1 Polynucleotide vaccine for papillomavirus |
| 01/11/1996 | WO1996000581A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | WO1996000580A1 Health composition |
| 01/11/1996 | WO1996000579A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
| 01/11/1996 | DE4423392A1 Verfahren zur Identifizierung antigener Peptide A method for identifying antigenic peptides |
| 01/11/1996 | DE4422859A1 Wäßrige Zellextrakte und wäßrige Suspensionen von Zellwandfraktionen aus Mykobacterien Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteriae |
| 01/11/1996 | DE4418690A1 Nucleoside 5'-mono-phosphate ester(s) of glyceryl di:ether derivs. |
| 01/11/1996 | CA2194138A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria |
| 01/11/1996 | CA2193828A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
| 01/11/1996 | CA2193802A1 Aav capsid vehicles for molecular transfer |
| 01/10/1996 | EP0691403A1 Family of primate IP-3-like hemapoietic growth factors |
| 01/10/1996 | EP0690914A1 Allergenic protein and peptides from house dust mite and uses therefor |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690849A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 01/10/1996 | EP0690722A1 Composition and method for reducing toxicity of biologically-active factors |
| 01/10/1996 | EP0690715A1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 01/10/1996 | EP0690713A1 Substituted alicyclic amine-containing macrocyclic immunomodulators |
| 01/10/1996 | EP0690710A1 Use of cis-9-heptadecenoic acid for treating psoriasis, allergies and autoimmune diseases |
| 01/10/1996 | EP0591255B1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
| 01/10/1996 | EP0558570B1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/10/1996 | EP0556241B1 Mycobacterium vaccae in the treatment of uveitis |
| 01/10/1996 | EP0482081B1 Antiviral composition |
| 01/09/1996 | US5482966 Oxime derivatives |
| 01/09/1996 | US5482963 Pharmaceutical agents useful as leukotriene antagonists |
| 01/09/1996 | US5482953 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharmaceuticals |
| 01/09/1996 | US5482949 Inhibiting bone loss, lowering cholesterol levels, and treating estrogen dependent mammary or uterine carcinoma |
| 01/09/1996 | US5482948 Pyridyl derivatives and pharmaceutical compositions comprising these compounds |
| 01/09/1996 | US5482945 Innovative technique for immunosuppression involving administration of rapamycin loaded formed blood elements |
| 01/09/1996 | US5482941 Quinazolinone antianginal agents |
| 01/09/1996 | US5482936 Imidazo[4,5-C]quinoline amines |
| 01/04/1996 | WO1996000238A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | WO1996000218A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000212A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 01/04/1996 | WO1996000082A1 Medical use of bromelain |
| 01/04/1996 | WO1996000078A1 Chinese herbs extract |
| 01/04/1996 | WO1996000068A2 Combination therapy for hiv infection |
| 01/04/1996 | WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 01/04/1996 | WO1995029193A3 Melanoma antigens |
| 01/04/1996 | DE4423131A1 Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4 New hIL-4 mutant proteins as antagonists or partial agonists of human interleukin 4 |
| 01/04/1996 | CA2193860A1 T cell epitopes of rye grass pollen allergen |
| 01/04/1996 | CA2193725A1 Aryl derivative compounds and uses to inhibit phosphodiesterase iv acti vity |
| 01/04/1996 | CA2193654A1 Medical use of bromelain |
| 01/04/1996 | CA2193221A1 Combination therapy for hiv infection |
| 01/03/1996 | EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors |
| 01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
| 01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
| 01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 01/03/1996 | EP0689596A1 Stimulation of immune response by viral protein |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0689546A1 Macrocyclic carbamate immunomodulators |
| 01/03/1996 | EP0689545A1 Macrocyclic amide and urea immunomodulators |
| 01/03/1996 | EP0689538A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 01/03/1996 | EP0689449A1 Therapeutical compositions for use in humans, characterised by a combination of a muramyl peptide and a cytokine |
| 01/03/1996 | EP0689446A1 Drugs for the treatment of retrovirus infections |
| 01/03/1996 | EP0689440A1 Use of triazine compounds as anxiolytics |
| 01/03/1996 | EP0689430A1 Superparamagnetic particles, process for producing the same and their use |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 01/03/1996 | EP0513104B1 USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED |
| 01/03/1996 | EP0440686B1 Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 01/03/1996 | CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors |
| 01/02/1996 | US5481043 Phenone compounds, manufacturing method and pharmaceutical preparations containing them |
| 01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
| 01/02/1996 | US5480912 Method of treating HIV-1 with α-substituted benzenemethanamine derivatives |
| 01/02/1996 | US5480895 Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof |
| 01/02/1996 | US5480887 Protease inhibitors |
| 01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
| 01/02/1996 | US5480660 Removal of proteins |
| 12/29/1995 | CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them |
| 12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
| 12/28/1995 | WO1995035321A1 Antibodies against t-cells as therapeutics |